serdexmethylphenidate
serdexmethylphenidate: 3 clinical trials tracked.
serdexmethylphenidate evidence translation
What we can confirm
3 tracked trials
What it means
What to watch
Prepared research question
What is verified about serdexmethylphenidate, and what remains unknown?
Traceable citations · Unknowns marked
See linked entities and source evidence1 indications · 1 study sponsors
Related indications
Study sponsors
Clinical Trial Registry Records (3)
A Multicenter, Dose-Optimized, Open-Label, Safety/Tolerability and Pharmacokinetic Study With Azstarys® in Children 4 and 5 Years of Age With Attention-Deficit/Hyperactivity Disorder
Primary endpoint: A determination of safety and tolerability of up to 12 months of treatment with Azstarys
A Multicenter, Dose-Optimized, Randomized, Double Blind, Efficacy and Safety Study With Azstarys® in Children 4 to 12 Years of Age With Attention Deficit/Hyperactivity Disorder
Primary endpoint: A Comparison of the Change in Mean ADHD Rating Scale (ADHD-RS) Results From Baseline to End of Treatment Between Active and Placebo Treatments.
A Phase 2, Placebo-Controlled, Double-Blind, Randomized Withdrawal Study to Determine the Safety and Efficacy of Oral SDX in Patients With Idiopathic Hypersomnia (IH)
Primary endpoint: Change From Baseline in Epworth Sleepiness Scale (ESS) Score